the role of immunotherapy in the aml treatment landscape
Published 2 years ago • 161 plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
2:11
the current role of immuno-oncology in aml and future outlooks
-
2:48
key targets and the future of immunotherapy in aml
-
3:40
how the aml treatment landscape has evolved with the use of novel combination therapies
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
14:43
current research into post-allosct maintenance therapy in aml
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
1:11:43
online webinar: acute myeloid leukaemia (aml) treatment update
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:40
the role of menin inhibitors in the treatment of aml
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
1:26
the role of vaccines in aml
-
2:34
the evolution of the aml treatment paradigm
-
0:59
the role of radioimmunoconjugates in aml treatment: insights from the sierra trial
-
11:19
immunotherapy for aml & all
-
7:52
advances in aml understanding: apl therapy, immunotherapy and maintenance therapy
-
2:14
update on the aml treatment landscape
-
1:29
risk-adapted therapy of aml
-
1:55
diagnosing and treating aml: the role of mutational profiling
-
1:42
novel treatment combinations in aml: what’s to come?